NASDAQ:PRSPPerspecta Stock Price, Forecast & News

Perspecta's stock was trading at $20.45 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, PRSP shares have increased by 8.4% and is now trading at $22.17. View which stocks have been most impacted by Coronavirus.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Perspecta in the last year. There are currently 5 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Perspecta.

Perspecta is scheduled to release its next quarterly earnings announcement on Wednesday, August 12th 2020. View our earnings forecast for Perspecta.

Perspecta Inc (NASDAQ:PRSP) issued its quarterly earnings results on Thursday, May, 21st. The company reported $0.55 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $0.53 by $0.02. The firm earned $1.10 billion during the quarter, compared to analyst estimates of $1.07 billion. The business's quarterly revenue was up .5% on a year-over-year basis. During the same period last year, the firm earned $0.54 earnings per share. View Perspecta's earnings history.

Perspecta announced a quarterly dividend on Friday, February 14th. Shareholders of record on Tuesday, March 3rd will be given a dividend of $0.06 per share on Wednesday, April 15th. This represents a $0.24 annualized dividend and a dividend yield of 1.08%. The ex-dividend date is Monday, March 2nd. View Perspecta's dividend history.

Perspecta updated its FY21 earnings guidance on Thursday, May, 21st. The company provided earnings per share guidance of $1.90-2.03 for the period, compared to the Thomson Reuters consensus estimate of $1.95. The company issued revenue guidance of $4.26-4.41 billion, compared to the consensus revenue estimate of $4.24 billion.

5 brokerages have issued 1-year price objectives for Perspecta's shares. Their forecasts range from $21.00 to $28.00. On average, they expect Perspecta's stock price to reach $23.75 in the next year. This suggests a possible upside of 7.1% from the stock's current price. View analysts' price targets for Perspecta.

Media coverage about PRSP stock has trended somewhat positive on Monday, according to InfoTrie Sentiment. The research group scores the sentiment of press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Perspecta earned a coverage optimism score of 1.4 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 3.0 out of 10, indicating that recent press coverage is unlikely to have an effect on the company's share price in the next several days. View the latest news aboutPerspecta.

Based on aggregate information from My MarketBeat watchlists, some companies that other Perspecta investors own include DXC Technology (DXC), Hewlett Packard Enterprise (HPE), HP (HPQ), AT&T (T), CVS Health (CVS), Alibaba Group (BABA), Cisco Systems (CSCO), Honeywell International (HON), Micro Focus International (MFGP) and Advanced Micro Devices (AMD).

Perspecta trades on the NASDAQ under the ticker symbol "PRSP."

Perspecta's stock is owned by many different institutional and retail investors. Top institutional investors include BlackRock Inc. (9.99%), William Blair Investment Management LLC (4.30%), State Street Corp (2.83%), Maverick Capital Ltd. (2.46%), Eagle Asset Management Inc. (2.20%) and Invesco Ltd. (1.85%). Company insiders that own Perspecta stock include John Kavanaugh, John M Curtis, Michael Earl Ventling and Philip O Nolan. View institutional ownership trends for Perspecta.

PRSP stock was sold by a variety of institutional investors in the last quarter, including Maverick Capital Ltd., Deutsche Bank AG, Balyasny Asset Management LLC, Principal Financial Group Inc., BlackRock Inc., Russell Investments Group Ltd., Morgan Stanley, and First Trust Advisors LP. View insider buying and selling activity for Perspecta.

PRSP stock was purchased by a variety of institutional investors in the last quarter, including William Blair Investment Management LLC, Samlyn Capital LLC, Invesco Ltd., Sunriver Management LLC, Primecap Management Co. CA, Matarin Capital Management LLC, AQR Capital Management LLC, and AXA. Company insiders that have bought Perspecta stock in the last two years include John Kavanaugh, John M Curtis, Michael Earl Ventling, and Philip O Nolan. View insider buying and selling activity for Perspecta.

Shares of PRSP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of PRSP stock can currently be purchased for approximately $22.17.

Perspecta has a market capitalization of $3.58 billion.